Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders

Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2013, Pages 93-101

  Kim, Hyun Ok ^a,b   Choi, Seong Mi ^a   Kim, Han Soo ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Mesenchymal stem cells; Microvesicles; Neurodegenerative disorders; Secretome

Indexed keywords

DISEASE CONTROL; FLOWCHARTING; NEURODEGENERATIVE DISEASES; STEM CELLS; TISSUE; TISSUE REGENERATION;

ANTI-INFLAMMATORIES; INFORMATION TRANSFERS; MESENCHYMAL STEM CELL; MICROVESICLES; NEURODEGENERATIVE DISORDERS; REGENERATIVE MEDICINE; SECRETOME; THERAPEUTIC EFFECTS;

CELL CULTURE;

ANGIOPOIETIN; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GALECTIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL THERAPY; CYTOKINE RELEASE; DEGENERATIVE DISEASE; EXOSOME; HUMAN; IMMUNOREGULATION; MESENCHYMAL STEM CELL; NEUROPROTECTION; NONHUMAN; PROTEIN SECRETION; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR;

EID: 84896735159     PISSN: 17382696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13770-013-0010-7     Document Type: Article

References (101)

1. AJ Friedenstein, RK Chailakhyan, NV Latsinik, et al., Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo, Transplantation, 17, 331 (1974).
2. MF Pittenger, AM Mackay, SC Beck, et al., Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143 (1999).
3. P Bianco, PG Robey, PJ Simmons, Mesenchymal stem cells: revisiting history, concepts, and assays, Cell Stem Cell, 2, 313 (2008).
4. RE Schwartz, M Reyes, L Koodie, et al., Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells, J Clin Invest 109, 1291 (2002).
5. J Sanchez-Ramos, S Song, F Cardozo-Pelaez, et al., Adult bone marrow stromal cells differentiate into neural cells in vitro, Exp Neurol, 164, 247 (2000).
6. Y Jiang, BN Jahagirdar, RL Reinhardt, et al., Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, 418, 41 (2002).
7. EM Horwitz, K Le Blanc, M Dominici, et al., Clarification of the nomenclature for MSC: the international society for cellular therapy position statement, Cytotherapy, 7, 393 (2005).
8. B Sacchetti, A Funari, S Michienzi, et al., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment, Cell, 131, 324 (2007).
9. M Dominici, K Le Blanc, I Mueller, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement, Cytotherapy, 8, 315 (2006).
10. M Gnecchi, LG Melo, Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium, Methods Mol Biol, 482, 281 (2009).
11. S Kim, JS Heo, HS Kim, et al., Isolation of mesenchymal stem cells from the mononuclear cells remaining in the bone marrow processing kit, Korean J Blood Transfusion, 21, 280 (2010).
12. W Wagner, REJ Feldmann, A Seckinger, et al., The heterogeneity of human mesenchymal stem cell preparations- evidence from simultaneous analysis of proteomes and transcriptomes, Exp Hematol, 34, 536 (2006).
13. S Mareddy, R Crawford, G Brooke, et al., Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis, Tissue Eng, 13, 819 (2007).
14. Y Xiao, S Mareddy, R Crawford, Clonal characterization of bone marrow derived stem cells and their application for bone regeneration, Int J Oral Sci, 2, 127 (2010).
15. K Sivasubramaniyan, D Lehnen, R Ghazanfari, et al., Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets, Ann NY Acad Sci, 1266, 94 (2012).
16. SP Bruder, NS Ricalton, RE Boynton, et al., Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation, J Bone Mineral Res, 13, 655 (1998).
17. RK Jaiswal, N Jaiswal, SP Bruder, et al., Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase, J Biol Chem, 275, 9645 (2000).
18. F Barry, RE Boynton, B Liu, et al., Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components, Exp Cell Res, 268, 189 (2001).
19. AH Reddi, Role of morphogenetic proteins in skeletal tissue engineering and regeneration, Nature Biotech, 16, 247 (1998).
20. T Gaur, CJ Lengner, H Hovhannisyan, et al., Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression, J Biol Chem, 280, 33132 (2005).
21. JH Kim, CS Cho, YH Choung, et al., Mechanical stimulation of mesenchymal stem cells for tissue engineering, Tissue Eng Reg Med, 6, 199 (2009).
22. S Makino, K Fukuda, S Miyoshi, et al., Cardiomyocytes can be generated from marrow stromal cells in vitro, J Clin Invest, 103, 697 (1999).
23. G Ferrari, G Cusella-De Angelis, M Coletta, et al., Muscle regeneration by bone marrow-derived myogenic progenitors, Science, 279, 1528 (1998).
24. Y Kashiwakura, Y Katoh, K Tamayose, et al., Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22alpha promoter: in vitro differentiation of putative smooth muscle progenitor cells of bone marrow, Circulation, 107, 2078 (2003).
25. GC Kopen, DJ Prockop, DG Phinney, Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proc Natl Acad Sci USA, 96, 10711 (1999).
26. J Chen, Y Li, L Wang, et al., Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats, J Neurol Sci, 189, 49 (2001).
27. BE Petersen, WC Bowen, KD Patrene, et al., Bone marrow as a potential source of hepatic oval cells, Science, 284, 1168 (1999).
28. E Lagasse, H Connors, M Al-Dhalimy, et al., Purified hematopoietic stem cells can differentiate into hepatocytes in vivo, Nature Med, 6, 1229 (2000).
29. NR Blondheim, YS Levy, T Ben-Zur, et al., Human mesenchymal stem cells express neural genes, suggesting a neural predisposition, Stem Cells Dev, 15, 141 (2006).
30. D Woodbury, EJ Schwarz, DJ Prockop, et al., Adult rat and human bone marrow stromal cells differentiate into neurons, J Neurosci Res, 61, 364 (2000).
31. YS Levy, D Merims, H Panet, et al., Induction of neuronspecific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells, J Mol Neurosci, 21, 121 (2003).
32. ML Khoo, B Shen, H Tao, et al., Long-term serial passage and neuronal differentiation capability of human bone marrow mesenchymal stem cells, Stem Cells Dev, 17, 883 (2008).
33. JL Spees, SD Olson, J Ylostalo, et al., Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma, Proc Natl Acad Sci USA, 100, 2397 (2003).
34. DG Phinney, DJ Prockop, Concise review: mesenchymal stem/ multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views, Stem Cells, 25, 2896 (2007).
35. S Kim, HS Kim, E Lee, et al., In vivo hepatic differentiation potential of human cord blood-derived mesenchymal stem cells, Int J Mol Med, 27, 701 (2011).
36. S Wislet-Gendebien, P Leprince, G Moonen, et al., Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells, J Cell Sci, 116, 3295 (2003).
37. T Tondreau, L Lagneaux, M Dejeneffe, et al., Bone marrowderived mesenchymal stem cells already express specific neural proteins before any differentiation, Differentiation, 72, 319 (2004).
38. J Deng, BE Petersen, DA Steindler, et al., Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation, Stem Cells, 24, 1054 (2006).
39. LR Zhao, WM Duan, M Reyes, et al., Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats, Exp Neurol, 174, 11 (2002).
40. G Keilhoff, A Goihl, K Langnäse, et al., Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells, Eur J Cell Biol, 85, 11 (2006).
41. YS Levy, M Bahat-Stroomza, R Barzilay, et al., Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease, Cytotherapy, 10, 340 (2008).
42. NL Kennea, SN Waddington, J Chan, et al., Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype, Cell Cycle, 8, 1069 (2009).
43. B Neuhuber, G Gallo, L Howard, et al., Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype, J Neurosci Res, 77, 192 (2004).
44. Y Iso, JL Spees, C Serrano, et al., Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment, Biochem Biophys Res Commun, 354, 700 (2007).
45. L von Bahr, I Batsis, G Moll, et al., Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation, Stem Cells, 30, 1575 (2012).
46. N Bertani, P Malatesta, G Volpi, et al., Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray, J Cell Sci, 118, 3925 (2005).
47. CB Choi, YK Cho, KV Prakash, et al., Analysis of neuron-like differentiation of human bone marrow mesenchymal stem cells, Biochem Biophys Res Commun, 350, 138 (2006).
48. T Tondreau, M Dejeneffe, N Meuleman, et al., Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells, BMC Genomics, 9, 166 (2008).
49. Y Li, J Chen, CL Zhang, et al., Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells, Glia, 49, 407 (2005).
50. PM Pimentel-Coelho, R Mendez-Otero, Cell therapy for neonatal hypoxicischemic encephalopathy, Stem Cells Dev, 19, 299 (2010).
51. YX Chao, BP He, SS Tay, Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease, J Neuroimmunol, 216, 39 (2009).
52. JK Lee, HK Jin, JS Bae, Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model, Neurosci Lett, 450, 136 (2009).
53. T Yasuhara, K Hara, M Maki, et al., Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxicischemic rats, J Cereb Blood Flow Metab, 28, 1804 (2008).
54. JS Jackson, JP Golding, C Chapon, et al., Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study, Stem Cell Res Ther, 1, 17 (2010).
55. S Kim, KA Chang, J Kim, et al., The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer's disease mice, PLoS One, 7, e45757 (2012).
56. NK Venkataramana, SK Kumar, S Balaraju, et al., Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease, Transl Res, 155, 62 (2010).
57. OY Bang, JS Lee, PH Lee, et al., Autologous mesenchymal stem cell transplantation in stroke patients, Ann Neurol, 57, 874 (2005).
58. D Karussis, C Karageorgiou, A Vaknin-Dembinsky, et al., Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis, Arch Neurol, 67, 1187 (2010).
59. PH Lee, JE Lee, HS Kim, et al., A randomized trial of mesenchymal stem cells in multiple system atrophy, Ann Neurol, 72, 32 (2012).
60. R Pal, NK Venkataramana, A Bansal, et al., Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study, Cytotherapy, 11, 897 (2009).
61. NA Kishk, H Gabr, S Hamdy, et al., Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury, Neurorehabil Neural Repair, 24, 702 (2010).
62. J Tolar, AJ Nauta, MJ Osborn, et al., Sarcoma derived from cultured mesenchymal stem cells, Stem cells, 25, 371 (2007).
63. HS Sohn, JS Heo, HS Kim, et al., Duration of in vitro storage affects the key stem cell features of human bone marrowderived mesenchymal stem cells for clinical transplantation, Cytotherapy, In Press, (2013).
64. SM Devine, AM Bartholomew, N Mahmud, et al., Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion, Exp Hematol, 29, 244 (2001).
65. MA Hellmann, H Panet, Y Barhum, et al., Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents, Neurosci Lett, 395, 124 (2006).
66. JR Chen, GY Cheng, CC Sheu, et al., Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke, J Anat, 213, 249 (2008).
67. HS Hong, J Lee, E Lee, et al., A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells, Nature Med, 15, 425 (2009).
68. H Yagi, A Soto-Gutierrez, B Parekkadan, et al., Mesenchymal stem cells: mechanisms of immunomodulation and homing, Cell Transplant, 19, 667 (2010).
69. D Woodbury, K Reynolds, IB Black, Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis, J Neurosci Res, 69, 908 (2002).
70. AA Mangi, N Noiseux, D Kong, et al., Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts, Nature Med, 9, 1195 (2003).
71. HS Kalluri, RJ Dempsey, Growth factors, stem cells, and stroke, Neurosurg Focus, 24, E14 (2008).
72. JR Munoz, BR Stoutenger, AP Robinson, et al., Human stem/ progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice, Proc Natl Acad Sci USA, 102, 18171 (2005).
73. AI Caplan, JE Dennis, Mesenchymal stem cells as trophic mediators, J Cell Biochem, 98, 1076 (2006).
74. L Crigler, RC Robey, A Asawachaicharn, et al., Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis, Exp Neurol, 198, 54 (2006).
75. VN Lama, L Smith, L Badri, et al., Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts, J Clin Invest, 117, 989 (2007).
76. MK Majumdar, MA Thiede, SE Haynesworth, et al., Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages, J Hematother Stem Cell Res, 9, 841 (2000).
77. T Kinnaird, E Stabile, MS Burnett, et al., Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms, Circulation, 109, 1543 (2004).
78. M Gnecchi, H He, OD Liang, et al., Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells, Nature Med, 11, 367 (2005).
79. L Timmers, SK Lim, F Arslan, et al., Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium, Stem Cell Res, 1, 129 (2007).
80. B Parekkadan, D van Poll, K Suganuma, et al., Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure, PLoS One, 2, e941 (2007).
81. GF Curley, M Hayes, B Ansari, et al., Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat, Thorax, 67, 496 (2012).
82. TJ Chuang, KC Lin, CC Chio, et al., Effects of secretome obtained from normoxia-preconditioned human mesenchymal stem cells in traumatic brain injury rats, J Trauma Acute Care Surg, 73, 1161 (2012).
83. DH Woo, SK Kim, HJ Lim, et al., Direct and indirect contribution of human embryonic stem cell-derived hepatocytelike cells to liver repair in mice, Gastroenterology, 142, 602 (2012).
84. J Ratajczak, K Miekus, M Kucia, et al., Embryonic stem cellderived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery, Leukemia, 20, 847 (2006).
85. H Valadi, K Ekström, A Bossios, et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nature Cell Biol, 9, 654 (2007).
86. J Skog, T Würdinger, S van Rijn, et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nature Cell Biol, 10, 1470 (2008).
87. J Nilsson, J Skog, A Nordstrand, et al., Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer, Br J Cancer, 100, 1603 (2009).
88. C D'Souza-Schorey, JW Clancy, Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers, Genes Dev, 26, 1287 (2012).
89. S Gatti, S Bruno, MC Deregibus, et al., Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury, Nephrol Dial Transplant, 26, 1474 (2011).
90. S Bruno, C Grange, F Collino, et al., Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury, PLoS One, 7, e33115 (2012).
91. J He, Y Wang, S Sun, et al., Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model, Nephrol, 17, 493 (2012).
92. RC Lai, F Arslan, MM Lee, et al., Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, Stem Cell Res, 4, 214 (2010).
93. MB Herrera, V Fonsato, S Gatti, et al., Human liver stem cellderived microvesicles accelerate hepatic regeneration in hepatectomized rats, J Cell Mol Med, 14, 1605 (2010).
94. F Collino, MC Deregibus, S Bruno, et al., Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs, PLoS One, 5, e11803 (2010).
95. HS Kim, DY Choi, SJ Yun, et al., Proteomic analysis of microvesicles derived from human mesenchymal stem cells, J Proteome Res, 11, 839 (2012).
96. L Alvarez-Erviti, Y Seow, H Yin, et al., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nature Biotech, 29, 341 (2011).
97. A Yuan, EL Farber, AL Rapoport, et al., Transfer of microRNAs by embryonic stem cell microvesicles, PLoS One, 4, e4722 (2009).
98. CA Ribeiro, AJ Salgado, JS Fraga, et al., The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures), J Tissue Eng Regen Med, 5, 668 (2011).
99. CA Ribeiro, JS Fraga, M Grãos, et al., The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations, Stem Cell Res Ther, 3, 18 (2012).
100. AP Horn, A Bernardi, R Luiz Frozza, et al., Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus, Stem Cells Dev, 20, 1171 (2011).
101. CP Chang, CC Chio, CU Cheong, et al., Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury, Clin Science, 124, 165 (2013).